ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 363 filers reported holding ASTRAZENECA PLC in Q4 2013. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $200,000 | -6.5% | 5,882 | -14.5% | 0.08% | -3.8% |
| Q1 2017 | $214,000 | -5.3% | 6,882 | 0.0% | 0.08% | -7.1% |
| Q3 2016 | $226,000 | +5.1% | 6,882 | -3.5% | 0.08% | +1.2% |
| Q2 2016 | $215,000 | +7.5% | 7,132 | 0.0% | 0.08% | +5.1% |
| Q1 2016 | $200,000 | -17.4% | 7,132 | 0.0% | 0.08% | -17.7% |
| Q4 2015 | $242,000 | +14.7% | 7,132 | +7.5% | 0.10% | +9.1% |
| Q3 2015 | $211,000 | -11.7% | 6,632 | +76.1% | 0.09% | 0.0% |
| Q2 2015 | $239,000 | -14.0% | 3,766 | -7.4% | 0.09% | -11.1% |
| Q1 2015 | $278,000 | -4.8% | 4,066 | -2.3% | 0.10% | -4.8% |
| Q4 2014 | $292,000 | -4.9% | 4,161 | -3.5% | 0.10% | -4.6% |
| Q3 2014 | $307,000 | -4.1% | 4,311 | 0.0% | 0.11% | +0.9% |
| Q2 2014 | $320,000 | -7.0% | 4,311 | -18.8% | 0.11% | -12.9% |
| Q1 2014 | $344,000 | 0.0% | 5,311 | -8.6% | 0.12% | -6.1% |
| Q4 2013 | $344,000 | +22.9% | 5,810 | +7.7% | 0.13% | +14.8% |
| Q3 2013 | $280,000 | -4.1% | 5,394 | -12.9% | 0.12% | -8.0% |
| Q2 2013 | $292,000 | – | 6,194 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |